Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-5,278,189 |
Prevention and treatment of occlusive cardiovascular disease with
ascorbate and substances that inhibit the... A method is provided for prevention and treatment of cardiovascular disease, such as atherosclerosis, by administering therapeutically effective dosages of a... |
| US-5,278,188 |
Method and composition for controlling the growth of microorganisms A microbial inhibiting composition and method is disclosed. The composition comprises an amount, effective for the intended purpose of decylthioethanamine... |
| US-5,278,187 |
Pharmaceutical compositions Compounds of formula (II) ##STR1## wherein R.sub.1 and R.sub.2 are each separately selected from hydrogen, alkyl, alkenyl and alkynyl groups having up to a... |
| US-5,278,186 |
Chromene derivatives, their production and use A chromene derivative of the formula (I) ##STR1## wherein each ring of A and B can have one or more substituents; X is an oxygen atom or sulfur atom, Y is... |
| US-5,278,185 |
Piperidine, Tetrahydropyridine and pyrrolidine compounds The invention relates to compounds of formula I: ##STR1## in which R.sub.1 represents a naphthyl radical, a dihydronaphthyl radical, a tetrahydronaphthyl... |
| US-5,278,184 |
Synthetic derivatives of pyrrole and pyrrolidine suitable for the
therapy of infections caused by rhinoviruses Antirhinoviral compounds having the formula ##STR1## wherein R is hetrocyclic, particularly pyrrole or pyrrolidine, X is H.sub.2 or O, n IS 3 to 7, and... |
| US-5,278,183 |
Method for the treatment of autoimmune diseases A pharmaceutical composition for the treatment of autoimmune diseases comprising an effective amount of a compound of formula where A is the nucleus of... |
| US-5,278,182 |
Azole-1-carboxylic acid ester derivatives and fungicidal compositions Disclosed is a azole-1-carboxylic acid ester derivative represented by the general formula ##STR1## wherein R is a lower alkyl, halo-lower alkyl, lower... |
| US-5,278,181 |
Soluble alkyl[5-[amino (phenyl)methyl]-1H-benzimidazol-2-yl] carbamate
anthelmintics Soluble alkyl [5-(amino (phenyl)methyl)-2H-benzimidazol-2-yl]carbamates, their enantiomorphic forms, and acid addition salts thereof are well absorbed and... |
| US-5,278,180 |
4,5-bis(aryl) 4H-1,2,4-triazoles derivatives and analgesic use A novel process for the preparation of 4H-1,2,4-triazoles in their racemic or optically active forms of the formula ##STR1## wherein the compounds have... |
| US-5,278,179 |
Pesticides based on substituted oxazolidinones, new substituted
oxazolidinones, and their preparation and use Substituted oxazolidinones, some of which are known, of the formula (I) ##STR1## in which R.sup.1 to R.sup.4 have the meanings given in the description, are... |
| US-5,278,178 |
Synergistic microbicidal combinations containing 3-isothiazolone and
commercial biocides This invention relates to synergistic antimicrobial and biocidal compositions comprising 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one... |
| US-5,278,177 |
Bicyclic heterocyclic derivatives as 5-lipoxygenase inhibitors The invention concerns a bicyclic heterocyclic derivative of the formula I ##STR1## wherein Q is an optionally substituted 9-membered bicyclic heterocyclic ... |
| US-5,278,176 |
Nicotine derivatives that enhance cognitive function Selective and potent nicotinic agonists of the formula: ##STR1## including pharmaceutically-acceptable salts or prodrugs thereof, useful in the treatment of... |
| US-5,278,175 |
Triazole antifungal agents The invention provide antifungal compounds of the formula: ##STR1## and pharmaceutically acceptable salts thereof, wherein R is phenyl substituted by 1 to 3... |
| US-5,278,174 |
Sigma binding site agents Sigma binding site agents having the formula ##STR1## which are useful to inhibit sigma binding site-induced activity, pharmaceutical compositions including... |
| US-5,278,173 |
Method of inhibiting the activity of human immunodeficiency virus (HIV)
in vivo A method for inhibiting the activity of human immunodeficiency virus (HIV) in vivo comprises administering to a human host an antimalarial drug, which is capable... |
| US-5,278,172 |
Method and composition for treating tendon or joint inflammation using a
vasodilator A process is provided which is useful in alleviating inflammation of tendons and/or joints in a patient in need of such treatment. The process comprises... |
| US-5,278,171 |
Azadecalin amides and thioamides as inhibitors of cholesterol
biosynthesis The present invention provides certain novel azadecalin amides and thioamides which are useful as inhibitors of cholesterol biosynthesis and as agents which... |
| US-5,278,170 |
Azabicylo oxime compounds A compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein R.sup.1 represents ##STR2## in which each of p and q... |
| US-5,278,169 |
Method of treating or prevention of fibrillation of the heart A method for the treatment and prevention of fibrillation using one or more potassium channel activators. Also, disclosed is a process for the preparation of... |
| US-5,278,168 |
Biological applications of alkaloids derived from the tunicate Eudistoma
sp. Biological applications of synthetic and natural alkaloids derived from the tunicate Eudistoma sp. are disclosed. A method regulating cell growth includes... |
| US-5,278,167 |
6-pyridyl substituted pyrimidine derivatives Novel 6-pyridyl substituted pyrimidine derivatives are disclosed for use as antiviral agents, particularly for the treatment of retroviral infections such as HIV... |
| US-5,278,166 |
4-amino-3-heteroaryl butyric acid compounds, compositions, and their use
for treating disorders involving a... A compound of formula (I): ##STR1## and medicinal products containing the same which are useful in treating disorders connected to a dysfunction of... |
| US-5,278,165 |
Oxazolyl imidazol[4,5-b]pyridin and pyrimidine compounds Oxazolyl derivatives of formula (I) ##STR1## wherein --A.sup.1 .dbd.A.sup.2 --A.sup.3 .dbd.A.sup.4 -- represents a bivalent radical having the formula R... |
| US-5,278,164 |
Treatment of anxiety in benzodiazepine-withdrawn patients A method of treatment of anxiety in benzodiazepine-withdrawn patients by administering BMY 14802 or, preferably, the R-(+)- enantiomer to a patient in need of... |
| US-5,278,163 |
Pyridazinone derivatives and compositions for controlling and/or
preventing insect pests A novel 3(2H)-pyradazinone derivative of the formula (I) ##STR1## wherein, R represents an alkyl group having 1 to 4 carbon atoms substituted by a... |
| US-5,278,162 |
3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one
useful in the treatment of cognitive... Compounds of Formula I have been shown to enhance the release of the neurotransmitters acetylcholine, dopamine and serotonin; and thus may be useful in the... |
| US-5,278,161 |
Amino acid derivatives useful as renin inhibitors Compounds of the formula ##STR1## wherein A, B, X, Y, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as set forth in the specification, in the form of... |
| US-5,278,160 |
Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of
various central nervous system disorders There are disclosed the use of the compounds of the formula (I) ##STR1## wherein R.sup.1 is 1-adamantyl, 3-methyl-1-adamantyl, 3-noradamantyl, unsubstituted... |
| US-5,278,159 |
Aryl ester derivatives of 3-oxo-4-aza-androstane 17-.beta.-carboxylates
as 5-.alpha.-reductase inhibitors Described are new 17.beta.-aryl ester carboxylates of 4-aza-5.alpha.-androstan-3-ones and related compounds and the use of such compounds as 5.alpha.-reductase... |
| US-5,278,158 |
Oxazinobenzazole compounds Oxazinobenzazole derivatives represented by the formula (I): ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4, which may be the same or different,... |
| US-5,278,157 |
Stable cephradine hydrate The invention relates to a novel stable form of cephradine, processes for its production and intermediates used therein. |
| US-5,278,156 |
11-beta, 17-alpha, 21-trihydroxy-1, 4-pregnadiene-3, 20 21-[(E-E)-3,7,
11-trimethyl-2,6,10-dodecatrienoate] 11.beta.,17.alpha.,21-Trihydroxy-1,4-pregnadiene-3,20-dione 21-[(E,E)-3,7,11-trimethyl-2,6,10-dodecatrienoate] of the formula ##STR1## an antiinflammatory... |
| US-5,278,155 |
Fluorine-containing vitamin D.sub.3 analogues and cell
differentiation-inducing agent containing the same Fluorine-containing vitamin D.sub.3 analogues of the formula [I]: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are independently hydrogen atom, a ... |
| US-5,278,154 |
New vanadium complexes Compounds of formula (I): ##STR1## in which: R.sub.1 or R.sub.4, which are identical or different, represent hydrogen or alkyl, R.sub.2 represents hydrogenm... |
| US-5,278,153 |
Aryl and heteroaryl (phosphinylmethyl)phosphonate squalene synthetase
inhibitors and method Phosphonic acid squalene synthetase inhibitors are provided which are effective in lowering serum cholesterol and have the formula ##STR1## wherein m is 0... |
| US-5,278,152 |
2-formylbenzylphosphonic acid derivatives useful for the treatment of
diseases caused by viruses The compound of the formula I ##STR1## in which R is an aldehyde group or a group which can be converted into an aldehyde, R.sup.1 and R.sup.2 are alkyl,... |
| US-5,278,151 |
Dry eye treatment solution A method and composition for reducing evaporation of an aqueous layer from the surface of the eye. The method comprises applying an admixture of a charged... |
| US-5,278,150 |
2-hydrazoadenosines and their utility for the treatmeat of vascular
conditions The present invention discloses a compound of the formula: ##STR1## where R.sub.1 is hydrogen or the group ##STR2## where R.sub.3 and R.sub.4 are the... |
| US-5,278,149 |
Method of preparing total parenteral nutrition solutions A method of preparing TPN solutions, which is particularly well adaptable to computerized control, has been developed. These methods can assist the pharmacist or... |
| US-5,278,148 |
Amino acid derivatives useful for treating high blood pressure Compounds of the formula ##STR1## wherein R.sup.1 is hydrogen or methyl, R.sup.2 is ethyl, propyl, isopropyl, imidazol-2-yl, imidazol-4-yl, pyrazol-3-yl,... |
| US-5,278,146 |
CRF analogs Analogs of CRF, which are based upon hCRF, oCRF, sauvagine and alpha-helical CRF, are disclosed that can be administered to achieve a substantial elevation of... |
| US-5,278,145 |
Method for protecting bone marrow against chemotherapeutic drugs using
transforming growth factor beta 1 The present invention relates to a method for protecting hematopoietic stem cells from the myelotoxicity of chemotherapeutic drugs or radiation therapy, which... |
| US-5,278,144 |
Antithrombosis agents Analogs of Factor Xa (Factor Xai) which are inactive as proteases in the prothrombinase reaction are useful in treatment of diseases characterized by thrombosis.... |
| US-5,278,143 |
Prophylactic and therapeutic methods for treating interleukin-mediated
edemas Unique methods for treating interleukin-mediated edemas in living subjects are provided comprising administering an effective amount of a composition selected... |
| US-5,278,142 |
Systemic delivery of polypeptides through the eye Compositions and methods for systemic delivery of polypeptides through the eyes are disclosed. The compositions include a systemically active polypeptide at a... |
| US-5,278,141 |
Fragrance compositions containing human pheromones The invention concerns novel, non-therapeutic fragrance compositions containing an odorant and a naturally occurring human pheromone. The invention also concerns... |
| US-5,278,140 |
Method for forming grain boundary junction devices using high T.sub.c
superconductors A method is disclosed for fabricating grain boundary junction devices, which comprises preparing a crystalline substrate containing at least one grain boundary... |
| US-5,278,139 |
Compound oxide high temperature superconducting material and a method
for preparing same A superconducting material and a process for producing a superconducting material comprising a compound oxide represented by the general formula: in which ".gamma."... |
Copyright 2008−2012 Patents.com
